Twin City Private Wealth’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,189
Closed -$587K 106
2026
Q1
$587K Buy
12,189
+30
+0.2% +$1.4K 0.45% 74
2025
Q4
$589K Buy
12,159
+293
+2% +$14.5K 0.45% 73
2025
Q3
$560K Sell
11,866
-1,971
-14% -$95.1K 0.44% 74
2025
Q2
$668K Buy
13,837
+2,365
+21% +$121K 0.55% 70
2025
Q1
$636K Sell
11,472
-359
-3% -$19.4K 0.56% 68
2024
Q4
$571K Buy
11,831
+1,189
+11% +$60.5K 0.5% 68
2024
Q3
$613K Sell
10,642
-1,585
-13% -$85.6K 0.53% 66
2024
Q2
$593K Buy
12,227
+1,584
+15% +$76.4K 0.56% 66
2024
Q1
$517K Buy
+10,643
New +$520K 0.51% 64

Other funds holding SNY

Twin City Private Wealth's SNY Position: Q2 2026 in Review

Twin City Private Wealth sold out of Sanofi (SNY) in Q2 2026, closing a stake of 12,189 shares — an estimated $587K sold.

Twin City Private Wealth first reported a position in SNY in Q1 2024 and held it in 9 quarters. The position peaked at $668K in Q2 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Twin City Private Wealth reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Twin City Private Wealth sold 12,189 Sanofi shares in Q2 2026, an estimated $587K.
  • Twin City Private Wealth first reported a position in Sanofi in Q1 2024 and held it in 9 quarters.
  • Twin City Private Wealth's Sanofi position peaked at $668K in Q2 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Twin City Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.